{"content":"<li class=\"n-box-item date-title\" data-end=\"1491019199\" data-start=\"1490932800\" data-txt=\"Sunday, December 22, 2019\">Friday, March 31, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3254917\" data-ts=\"1490998956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORBC\" target=\"_blank\">ORBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254917-orbcomm-prices-250m-in-senior-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orbcomm prices $250M in senior notes</a></h4><ul>   <li>Orbcomm (<a href=\"http://seekingalpha.com/symbol/ORBC\" target=\"_blank\">ORBC</a> <font color='green'>+3.1%</font>) has <a href=\"https://seekingalpha.com/pr/16787449-orbcomm-announces-pricing-offering-250000-000-senior-secured-notes-due-2024\" target=\"_blank\">priced an offering</a> of $250M in senior debt.</li>    <li>The company is offering that amount in 8% senior secured notes due 2024. Net proceeds are earmarked to repay $150M in outstanding debt under existing $160M secured credit facilities.</li>    <li>Total debt at last report was $148.7M. The company had just over $25M in cash.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/ORBC' title='ORBCOMM Inc.'>ORBC</a> <font color='red'>-3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254917\" data-linked=\"Orbcomm prices $250M in senior notes\" data-tweet=\"$ORBC - Orbcomm prices $250M in senior notes https://seekingalpha.com/news/3254917-orbcomm-prices-250m-in-senior-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3254917-orbcomm-prices-250m-in-senior-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254913\" data-ts=\"1490997627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254913-mylan-expands-epipen-recall-to-cover-u-s-lots\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan expands EpiPen recall to cover U.S. lots</a></h4><ul>   <li>Mylan (<a href=\"http://seekingalpha.com/symbol/MYL\" target=\"_blank\">MYL</a> <font color='red'>-1.5%</font>) has expanded a recall of EpiPen auto-injectors to include <a href=\"https://seekingalpha.com/pr/16787406-mylan-provides-update-meridian-medical-technologies-pfizer-company-expanded-voluntary\" target=\"_blank\">additional lots in the United States</a>.</li>    <li>Meridian Medical Technologies, the drugmaker's manufacturing partner, expanded the recall of several lots of EpiPen and EpiPen Jr based on a pair of reports (from outside the country) of the device failing to activate.</li>    <li>The company says the recall is being expanded as a precautionary measure. Lots included were manufactured and distributed between December 2015 and July 2016, of 0.3 mg and 0.15 mg strengths, and the expanded recall covers not only the U.S. but also additional markets in Europe, Asian, North America and South America.</li>    <li>Shares are <font color='red'>down another 2%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254913\" data-linked=\"Mylan expands EpiPen recall to cover U.S. lots\" data-tweet=\"$MYL - Mylan expands EpiPen recall to cover U.S. lots https://seekingalpha.com/news/3254913-mylan-expands-epipen-recall-to-cover-u-s-lots?source=tweet\" data-url=\"https://seekingalpha.com/news/3254913-mylan-expands-epipen-recall-to-cover-u-s-lots\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254904\" data-ts=\"1490996248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254904-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='green'>+5.5%</font>. <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/IWC' title='iShares Micro-Cap ETF'>IWC</a> <font color='green'>+3.0%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-7.9%</font>. <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a> <font color='red'>-1.9%</font>. <a href='https://seekingalpha.com/symbol/DEM' title='WisdomTree Emerging Markets High Dividend ETF'>DEM</a> <font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/VWO' title='Vanguard FTSE Emerging Markets ETF'>VWO</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a> <font color='red'>-1.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254904\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$FCG $USO $BNO - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3254904-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3254904-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254864\" data-ts=\"1490989105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254864-petrobras-targets-five-major-assets-for-renewed-divestment-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras targets five major assets for renewed divestment program</a></h4><ul>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+1.6%</font>) says it is eyeing five major assets for a <a href=\"http://www.reuters.com/article/petrobras-divestiture-idUSL2N1H80HK\" target=\"_blank\">renewed divestment program</a> to be formalized in the next two weeks, after a court forced it to restart most of its $21B asset sale program from scratch.</li>     <li>PBR says new sales may include fuel distribution unit BR Distribuidora, shallow offshore fields in the states of Sergipe and Cear&aacute;, the Ba&uacute;na and Tartaruga Verde oil fields in the Santos and Campos Basins, onshore fields in the state of Sergipe, and deepwater rights in the Gulf of Mexico.</li>     <li>Since CEO Pedro Parente came aboard in May 2016, PBR has pursued aggressive asset sales as it sought to cut the largest debt burden among global oil firms.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254864\" data-linked=\"Petrobras targets five major assets for renewed divestment program\" data-tweet=\"$PBR - Petrobras targets five major assets for renewed divestment program https://seekingalpha.com/news/3254864-petrobras-targets-five-major-assets-for-renewed-divestment-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3254864-petrobras-targets-five-major-assets-for-renewed-divestment-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254859\" data-ts=\"1490987147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254859-wecast-networkminus-1_8-fy-report-turns-page-on-you-on-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wecast Network -1.8% as FY report turns page on You On Demand</a></h4><ul>   <li>Wecast Network (WCST) is <font color='red'>off 1.8%</font> today after posting <a href=\"https://seekingalpha.com/news/3254685-wecast-network-reports-fy-results\" target=\"_blank\">earnings</a> that reflected the company's makeover from the former You On Demand.</li>    <li>After a revenue decline in 2016 to $4.54M, it's guiding to 2017 revenues of $280M-$300M (a 66-fold increase). Q1 will feature about five weeks of revenue from the company's new businesses (<a href=\"https://seekingalpha.com/news/3239516-wecast-network-plus-16_5-percent-closes-sun-video-higher-revenue-target\" target=\"_blank\">notably Sun Video Group</a>), and revenues will ramp through the rest of the year, CEO Bing Yang says.</li>    <li>As part of the Sun Video Group deal, SVG guaranteed it would hit revenue milestones (revised up to $250M) within 12 months of closing or forfeit back to Wecast stock and a promissory note.</li>    <li>For 2016, gross profit fell to $110,000 from 2015's $932,000. SG&amp;A expenses rose 26% to $10.37M, mainly due to bad debt expense of $2.589M.</li>    <li><a href=\"https://seekingalpha.com/pr/16786686-wecast-network-announces-q4-full-year-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254859\" data-linked=\"Wecast Network -1.8% as FY report turns page on You On Demand\" data-tweet=\"$SSC-OLD - Wecast Network -1.8% as FY report turns page on You On Demand https://seekingalpha.com/news/3254859-wecast-networkminus-1_8-fy-report-turns-page-on-you-on-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3254859-wecast-networkminus-1_8-fy-report-turns-page-on-you-on-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254857\" data-ts=\"1490986865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254857-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='green'>+18%</font>. COOL <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+12%</font>. BBRY <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='red'>-7%</font>. MSDI <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254857\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$SFUN $IDN $PTE - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3254857-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254857-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254851\" data-ts=\"1490984632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSRI\" target=\"_blank\">SSRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254851-silver-standard-resolves-argentinian-export-dispute-shares-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silver Standard resolves Argentinian export dispute; shares halted</a></h4><ul>     <li>Silver Standard Resources (<a href='https://seekingalpha.com/symbol/SSRI' title='SSR Mining Inc'>SSRI</a> <font color='green'>+1.8%</font>) says it will <a href=\"https://seekingalpha.com/pr/16787200-silver-standard-resolves-export-duty-claim-argentina\" target=\"_blank\">receive ~1B Argentine pesos</a> in a resolution of a dispute with the country's tax authorities over the application of export duties on its Pirquitas mine; shares are halted.</li>     <li>SSRI also says it will <a href=\"https://seekingalpha.com/pr/16787201-silver-standard-exercises-option-form-joint-venture-golden-arrow-chinchillas-project\" target=\"_blank\">exercise its option</a> on the Chinchillas project and form a joint venture with Golden Arrow Resources for development of the property.</li>     <li>SSRI says the resolution provides the certainty required to exercise its option on Chinchillas.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254851\" data-linked=\"Silver Standard resolves Argentinian export dispute; shares halted\" data-tweet=\"$SSRI - Silver Standard resolves Argentinian export dispute; shares halted https://seekingalpha.com/news/3254851-silver-standard-resolves-argentinian-export-dispute-shares-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3254851-silver-standard-resolves-argentinian-export-dispute-shares-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254849\" data-ts=\"1490983318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254849-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc Ordinary Sh'>HBM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254849\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$MPVD $FMC $AAU - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3254849-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254849-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254847\" data-ts=\"1490983273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254847-bet-on-selfie-generation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A bet on the &#39;selfie generation&#39;</a></h4><ul><li>As expected, the e.l.f. Beauty (<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='green'>+4.1%</font>) share offering was priced at $7 today.</li><li>The offering was upsized to 8.3M shares from 7M shares.</li><li>On <a href=\"http://www.cnbc.com/top-video/\" target=\"_blank\">CNBC</a> today, Jim Cramer theorized that demand is high for shares of e.l.f. with the cosmetics seller viewed as benefiting from strong demand by the \"selfie generation\" for economical makeup.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254793-offering-e-l-f-beauty-said-price-27\" target=\"_blank\">Offering from e.l.f. Beauty said to price at $27</a> (March 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254847\" data-linked=\"A bet on the &#39;selfie generation&#39;\" data-tweet=\"$ELF - A bet on the &#39;selfie generation&#39; https://seekingalpha.com/news/3254847-bet-on-selfie-generation?source=tweet\" data-url=\"https://seekingalpha.com/news/3254847-bet-on-selfie-generation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254842\" data-ts=\"1490981950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLY\" target=\"_blank\">XLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254842-consumer-discretionary-spdr-hits-another-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Discretionary SPDR hits another all-time high</a></h4><ul><li>Retail woes are making plenty of headlines these days, but the Consumer Discretionary SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>) was the only ETF to <a href=\"http://www.barrons.com/articles/youll-never-guess-which-sector-etf-made-a-new-high-1490978179\" target=\"_blank\">hit a new all-time high</a> on Thursday (after doing same on Wednesday). It's in the green again today.</li><li>Helping is a near-14% weighting for Amazon, which also seems to be hitting fresh all-time highs on a daily basis (it's&nbsp;<font color='green'>up another 1.5%</font>&nbsp;today).</li><li><a href=\"http://www.etfinvestmentoutlook.com/etf_holdings.php?s=XLY\" target=\"_blank\">Other top holdings include</a> Home Depot, Comcast, Disney, McDonald's, and Starbucks. One has to get way down the list to Target (1.8% of fund) to find a name truly being disrupted (for now) by Amazon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254842\" data-linked=\"Consumer Discretionary SPDR hits another all-time high\" data-tweet=\"$XLY - Consumer Discretionary SPDR hits another all-time high https://seekingalpha.com/news/3254842-consumer-discretionary-spdr-hits-another-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3254842-consumer-discretionary-spdr-hits-another-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254841\" data-ts=\"1490981567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTHR\" target=\"_blank\">UTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254841-united-therapeutics-loses-treprostinil-patent-challenge-shares-slip-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Therapeutics loses treprostinil patent challenge; shares slip 2%</a></h4><ul><li>United Therapeutics (<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color='red'>-1.5%</font>) moves into the red after the U.S. Patent Trial and Appeal Board &#40;PTAB&#41; rules that all the claims of U.S. Patent No. 8,497,393 ('393 patent) covering treprostinil are not patentable. Watson Laboratories and Actavis Laboratories challenged the patent with the aim of launching generic versions.</li><li>The company is assessing its options, including a rehearing before the PTAB or appeal to the U.S. Court of Appeals for the Federal Circuit.</li><li>Treprostinil is the active ingredient in <a href=\"https://www.remodulin.com/\" target=\"_blank\">Remodulin</a>, <a href=\"https://www.tyvaso.com/dtc\" target=\"_blank\">Tyvaso </a>and <a href=\"https://www.orenitram.com/\" target=\"_blank\">Orenitram</a>. The three products accounted for almost 70% of the company's Q4 sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254841\" data-linked=\"United Therapeutics loses treprostinil patent challenge; shares slip 2%\" data-tweet=\"$UTHR - United Therapeutics loses treprostinil patent challenge; shares slip 2% https://seekingalpha.com/news/3254841-united-therapeutics-loses-treprostinil-patent-challenge-shares-slip-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3254841-united-therapeutics-loses-treprostinil-patent-challenge-shares-slip-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254838\" data-ts=\"1490980504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254838-report-apple-may-bid-for-toshiba-memory-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Apple may bid for Toshiba Memory business</a></h4><ul>   <li>While speculation on bidders for Toshiba's (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='green'>+2.3%</font>) NAND business has centered on Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>), as well as Micron, Western Digital and SK Hynix, Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color='green'>+0.1%</font>) may be among bidders as well, according to a Japanese publication.</li>    <li><a href=\"http://blogs.barrons.com/asiastocks/2017/03/31/toshiba-now-rumors-say-apple-is-interested-in-bidding-for-nand-business/\" target=\"_blank\">Barron's notes</a> that a Google translation of <a href=\"https://translate.google.com/translate?sl=ja&amp;tl=en&amp;js=y&amp;prev=_t&amp;hl=en&amp;ie=UTF-8&amp;u=http%3A%2F%2Fwww.yomiuri.co.jp%2Feconomy%2F20170331-OYT1T50043.html&amp;edit-text=\" target=\"_blank\">Yomiuri Shimbun</a> suggests such a purchase is interesting Apple as well.</li>    <li>Fair value for Toshiba Memory may be around &yen;1T, though Toshiba would like to see &yen;2T (about $17.9B), and that's the price reports are attaching to the Broadcom/Silver Lake bid.</li>    <li>Broadcom has returned to positive ground on the day, <font color='green'>up 0.2%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254822-analysts-debate-broadcom-interest-toshiba-memory-chips\" target=\"_blank\">Analysts debate Broadcom interest in Toshiba memory chips</a> (Mar. 31 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254838\" data-linked=\"Report: Apple may bid for Toshiba Memory business\" data-tweet=\"$AVGO $AVGO $TOSYY - Report: Apple may bid for Toshiba Memory business https://seekingalpha.com/news/3254838-report-apple-may-bid-for-toshiba-memory-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3254838-report-apple-may-bid-for-toshiba-memory-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254834\" data-ts=\"1490979686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254834-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NWFL' title='Norwood Financial Corp.'>NWFL</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PEBK' title='Peoples Bancorp of North Carolina, Inc.'>PEBK</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254834\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$NWFL $PEBK - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3254834-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254834-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254832\" data-ts=\"1490979219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254832-alcoaplus-3-after-bmo-upgrade-on-aluminum-pricing-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa +3% after BMO upgrade on aluminum pricing strength</a></h4><ul>     <li>Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+3.2%</font>) is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9242012/4-reasons-bmo-upgraded-the-new-alcoa\" target=\"_blank\">upgraded</a> to Outperform from Market Perform with a $45 price target, raised from $35, at BMO Capital, which says the recent disconnect between aluminum and alumina prices and undervalued Alcoa shares have created a buying opportunity.</li>     <li>BMO says if aluminum and alumina prices remain just flat from today's levels, Alcoa shares could see upside of 30%-40%, and if aluminum and alumina prices move higher by just 10%, then AA shares could enjoy 60% upside.</li>     <li>But the firm also cautions that Alcoa's \"new\" shares are extremely sensitive to small changes in commodity prices, and the upgrade is based on prices remaining relatively near current levels throughout the next 6-12 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254832\" data-linked=\"Alcoa +3% after BMO upgrade on aluminum pricing strength\" data-tweet=\"$AA - Alcoa +3% after BMO upgrade on aluminum pricing strength https://seekingalpha.com/news/3254832-alcoaplus-3-after-bmo-upgrade-on-aluminum-pricing-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3254832-alcoaplus-3-after-bmo-upgrade-on-aluminum-pricing-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254831\" data-ts=\"1490979047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254831-court-invalidates-four-ampyra-patents-acorda-plummets-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Court invalidates four Ampyra patents; Acorda plummets 24%</a></h4><ul><li>Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-23.9%</font>) is under pressure after a Delaware district court <a href=\"https://seekingalpha.com/pr/16787129-u-s-district-court-issues-decision-invalidate-four-ampyra-patents-company-will-appeal-ruling\" target=\"_blank\">ruled </a>that four patents ('685, '826, '703 and '437) covering MS med AMPYRA (dalfampridine) are invalid. One patent ('938) was upheld.</li><li>The company says it will appeal the decision.</li><li>AMPYRA accounts for almost all of Acorda's sales, projected to be $535M - 545M this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254831\" data-linked=\"Court invalidates four Ampyra patents; Acorda plummets 24%\" data-tweet=\"$ACOR - Court invalidates four Ampyra patents; Acorda plummets 24% https://seekingalpha.com/news/3254831-court-invalidates-four-ampyra-patents-acorda-plummets-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3254831-court-invalidates-four-ampyra-patents-acorda-plummets-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254829\" data-ts=\"1490978838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254829-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TRR' title='TRC Companies, Inc.'>TRR</a> <font color='green'>+46%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/CIDM' title='Cinedigm Corp.'>CIDM</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/FC' title='Franklin Covey Company'>FC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/STKS' title='The ONE Group Hospitality, Inc.'>STKS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/DXPE' title='DXP Enterprises, Inc.'>DXPE</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CTSO' title='Cytosorbents Corp'>CTSO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/EDUC' title='Educational Development Corporation'>EDUC</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254829\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$TRR $AKTX $CIDM - Midday Gainers / Losers https://seekingalpha.com/news/3254829-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3254829-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254822\" data-ts=\"1490977505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HXSCF\" target=\"_blank\">HXSCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254822-analysts-debate-broadcom-interest-in-toshiba-memory-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts debate Broadcom interest in Toshiba memory chips</a></h4><ul>   <li>UBS analyst Stephen Chin isn't surprised that Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='red'>-0.2%</font>) may be <a href=\"https://seekingalpha.com/news/3254635-toshiba-offered-17_9b-chip-unit\" target=\"_blank\">making a play</a> for the second-largest NAND chipmaker by market share -- Toshiba's (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='green'>+3.2%</font>).</li>    <li>Among several hurdles to the deal, Broadcom has <a href=\"http://www.investors.com/news/technology/broadcom-joins-bidding-for-toshiba-chip-unit/\" target=\"_blank\">key attributes in its favor</a> as well: \"We are not sure if a deal will happen and note the Nikkei reported there are 10 bidders ... But if it were to, we believe the key positives for Broadcom could include: 1) successful track record integrating acquisitions, 2) delivers on (earnings per share) accretion targets, and 3) big expansion of their total addressable market.\"</li>    <li>Meanwhile, RBC's Amit Daryanani thinks Broadcom isn't in it to run a giant NAND business, but to be a minority bidder with Silver Lake to \"a) acquire small non-memory assets within the division (controllers, etc.) and/or b) Broadcom is doing a passive investment with Silver Lake being the primary bidder.\"</li>    <li>Shareholders approved the spinoff of Toshiba Memory yesterday, part of moves to make up for a Westinghouse bankruptcy. But governmental security issues around advanced hardware encryption will prove a hurdle to the sale.</li>    <li>Rival bidders include Micron (<a href=\"http://seekingalpha.com/symbol/MU\" target=\"_blank\">MU</a> <font color='green'>+0.5%</font>), Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='red'>-0.9%</font>) and SK Hynix (<a href='https://seekingalpha.com/symbol/HXSCF' title='SK Hynix, Inc.'>OTC:HXSCF</a>) among others. A purchase of the world's second-largest NAND maker would be a boon for any.</li>    <li>Toshiba will talk with candidates next month before a second round of bidding, Nikkei says, and will be looking to determine whether a buyer will eventually re-sell its stake in the business.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254822\" data-linked=\"Analysts debate Broadcom interest in Toshiba memory chips\" data-tweet=\"$HXSCF $HXSCF $AVGO - Analysts debate Broadcom interest in Toshiba memory chips https://seekingalpha.com/news/3254822-analysts-debate-broadcom-interest-in-toshiba-memory-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3254822-analysts-debate-broadcom-interest-in-toshiba-memory-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254818\" data-ts=\"1490977012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FWP\" target=\"_blank\">FWP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254818-biogen-wins-tecfidera-patent-interference-case-against-forward-pharma-fwp-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen wins Tecfidera patent interference case against Forward Pharma, FWP down 18%</a></h4><ul><li>Forward Pharma (<a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-17.9%</font>) slumps on increased volume in response to the news that Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+1.3%</font>) has prevailed in their patent interference proceeding related to MS drug Tecfidera (dimethyl fumarate). Developing....</li><li>On February 9, Biogen paid Forward $1.25B related to the patent covering methods of treating MS patients, which Forward asserted it filed before Biogen.</li><li>Alkermes (<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color='green'>+0.4%</font>) is developing an oral monomethyl fumarate prodrug for MS (ALKS 8700)&nbsp;which is designed to be gentler on the GI tract than Tecfidera. Shares have dropped&nbsp;<font color='red'>~4%</font>&nbsp;from the intraday high of $61.80 but are still in the green.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3235416-biogen-pay-forward-pharma-1_25b-patent-infringement-case-related-ms-med-tecfidera-forward-74\" target=\"_blank\">Biogen to pay Forward Pharma $1.25B in patent infringement case related to MS med Tecfidera; Forward up 74% premarket</a> (Jan. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254818\" data-linked=\"Biogen wins Tecfidera patent interference case against Forward Pharma, FWP down 18%\" data-tweet=\"$FWP $FWP $BIIB - Biogen wins Tecfidera patent interference case against Forward Pharma, FWP down 18% https://seekingalpha.com/news/3254818-biogen-wins-tecfidera-patent-interference-case-against-forward-pharma-fwp-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3254818-biogen-wins-tecfidera-patent-interference-case-against-forward-pharma-fwp-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254820\" data-ts=\"1490976597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254820-beans-down-corn-higher-after-usda-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beans down, corn higher after USDA report</a></h4><ul><li>Soybeans are<font color='red'> lower by nearly 2%</font>&nbsp;after <a href=\"https://www.usda.gov/media/agency-reports\" target=\"_blank\">the USDA estimates</a> planted acres at 89.482M acres vs. trade forecasts for 88.214M. The agency also sees March 1 stocks at 1.735B bushels, just above the top end of the expected range.</li><li>Corn planting intentions are somewhat soft - 89.996M acres vs. expectations for 90.97M. March 1 stocks are above estimates. Corn is<font color='green'> higher by 1%</font>.</li><li>Wheat planting intentions are 46.059M acres vs. forecasts for 46.139M. March 1 stocks are above estimates. Wheat's&nbsp;<font color='green'>up 0.2%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/CORN' title='Teucrium Corn ETF'>CORN</a>, <a href='https://seekingalpha.com/symbol/JJG' title='iPath DJ-UBS Grains Total Return Sub-Index ETN'>JJG</a>, <a href='https://seekingalpha.com/symbol/WEAT' title='Teucrium Wheat Fund'>WEAT</a>, <a href='https://seekingalpha.com/symbol/SOYB' title='Teucrium Soybean Fund'>SOYB</a>, <a href='https://seekingalpha.com/symbol/GRU' title='ELEMENTS MLCX Grains Index Total Return ETN'>GRU</a>, <a href='https://seekingalpha.com/symbol/WEET' title='iPath Pure Beta Grains ETN'>WEET</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254820\" data-linked=\"Beans down, corn higher after USDA report\" data-tweet=\"$CORN $JJGTF $WEAT - Beans down, corn higher after USDA report https://seekingalpha.com/news/3254820-beans-down-corn-higher-after-usda-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3254820-beans-down-corn-higher-after-usda-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254819\" data-ts=\"1490976099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254819-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/FBR' title='Fibria Celulose S.A.'>FBR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-8%</font>. SPU <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254819\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $PRMW $FBR - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3254819-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254819-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254807\" data-ts=\"1490973642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254807-endologixs-ide-study-of-ovation-alto-stent-graft-underway-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix&#39;s IDE study of Ovation Alto Stent Graft underway; shares up 2%</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16786670-endologix-inc-announces-enrollment-first-patients-elevate-ide-clinical-study\" target=\"_blank\">first patients have been treated</a> in an IDE study, ELEVATE, assessing Endologix's (<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a> <font color='green'>+1.9%</font>) Polymer Sealing Ovation Alto Stent Graft for the repair of infrarenal (below the kidney) abdominal aortic aneurysms. The 12-site study will enroll 75 subjects.</li><li>The Ovation Alto is the newest device in the company's <a href=\"https://endologix.com/united-states/products/ovation/\" target=\"_blank\">Ovation </a>line of abdominal stent graft systems. The company says it expands endovascular aneurysm repair &#40;EVAR&#41; to a larger population of patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254807\" data-linked=\"Endologix&#39;s IDE study of Ovation Alto Stent Graft underway; shares up 2%\" data-tweet=\"$ELGX - Endologix&#39;s IDE study of Ovation Alto Stent Graft underway; shares up 2% https://seekingalpha.com/news/3254807-endologixs-ide-study-of-ovation-alto-stent-graft-underway-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3254807-endologixs-ide-study-of-ovation-alto-stent-graft-underway-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254785\" data-ts=\"1490972496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254785-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BCLI' title='BrainStorm Cell Therapeutics Inc.'>BCLI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='red'>-17%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254785\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$AKTX $DRNA $BCLI - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3254785-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3254785-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254799\" data-ts=\"1490971206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVN\" target=\"_blank\">LIVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254799-livanova-announces-cfo-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LivaNova announces CFO resignation</a></h4><ul>     <li>LivaNova (<a href='https://seekingalpha.com/symbol/LIVN' title='LivaNova PLC'>LIVN</a> <font color='red'>-3.9%</font>) announced that its CFO, Vivid Sehgal, is leaving the company to pursue other opportunities.</li><li>The company has an external search underway to identify a replacement. Sehgal will continue as CFO and will support an orderly transition to his successor.</li>     <li>&ldquo;Vivid has been the company&rsquo;s CFO since its inception in October 2015 and has been an integral part of our Executive Leadership team,&rdquo; said Damien McDonald, LivaNova&rsquo;s Chief Executive Officer. &ldquo;His leadership, insights and guidance have been instrumental in building a strong team, while establishing financial disciplines across the portfolio. His presence, knowledge and leadership will be important through the transition period. We wish to thank him for his many contributions in helping to position the company for sustainable growth.&rdquo;</li><li><a href=\"https://seekingalpha.com/pr/16786870-livanova-plc-announces-chief-financial-officer-resignation\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254799\" data-linked=\"LivaNova announces CFO resignation\" data-tweet=\"$LIVN - LivaNova announces CFO resignation https://seekingalpha.com/news/3254799-livanova-announces-cfo-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3254799-livanova-announces-cfo-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254792\" data-ts=\"1490969625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FC\" target=\"_blank\">FC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254792-post-earnings-rally-for-franklin-covey\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally for Franklin Covey</a></h4><ul> <li>Franklin Covey (<a href='https://seekingalpha.com/symbol/FC' title='Franklin Covey Company'>FC</a> <font color='green'>+12.1%</font>) rallies after recording an increase in gross margin rate for <a href=\"https://seekingalpha.com/pr/16786359-franklin-covey-reports-fiscal-2017-second-quarter-financial-results\" target=\"_blank\">FQ2</a>. The company posted an operating loss of $4.5M during the quarter after extra costs factored in amid a change to the AAP business model.</li> <li>\"We believe that the transition to the All Access Pass business model will provide growth in future periods through higher initial sale sizes, consistently strong renewals, and from sales of add-on services and training materials,\" says CEO Bob Whitman.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3254792\" data-linked=\"Post-earnings rally for Franklin Covey\" data-tweet=\"$FC - Post-earnings rally for Franklin Covey https://seekingalpha.com/news/3254792-post-earnings-rally-for-franklin-covey?source=tweet\" data-url=\"https://seekingalpha.com/news/3254792-post-earnings-rally-for-franklin-covey\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254787\" data-ts=\"1490968727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254787-fang-holdingsplus-6_4-states-return-to-former-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings +6.4% as it states return to former strategy</a></h4><ul>   <li>Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>) is <font color='green'>up 6.4%</font> out of the open after <a href=\"https://seekingalpha.com/news/3254709-soufun-holdings-misses-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a> in which revenues missed, but the company acknowledged its restructuring challenges and said it would return to an open-platform strategy.</li>    <li>\"I admit that our two-year long transformation is a failure up to today,\" said CEO Vincent Mo. \"We did not know in depth of the new markets and new business lines. We were too aggressive in transformations at the same time with all of our business lines.\"</li>    <li>The company lost $6.4M from operations; net loss was $8.9M.</li>    <li>Revenues fell 42% mainly due to a decline in e-commerce (down 48%) and marketing services (down 42%). Listing services revenue, meanwhile, was up 74% to $38.6M.</li>    <li>At Dec. 31, Fang had cash, equivalents and short-term investments of $590.5M, down from the prior year's $983.7M.</li>    <li>As for guidance, it says it's \"undergoing adjustments to its transformations\" and is planning to return to open-platform strategy -- so it expects a decrease in top-line revenue but expects profitability for the full year. Consensus expectations are that the company will make $0.10/share ($0.07 on GAAP basis) in 2017.</li>    <li><a href=\"https://seekingalpha.com/pr/16786732-fang-announces-fourth-quarter-fiscal-year-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254787\" data-linked=\"Fang Holdings +6.4% as it states return to former strategy\" data-tweet=\"$SFUN - Fang Holdings +6.4% as it states return to former strategy https://seekingalpha.com/news/3254787-fang-holdingsplus-6_4-states-return-to-former-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3254787-fang-holdingsplus-6_4-states-return-to-former-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254778\" data-ts=\"1490967511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GENE\" target=\"_blank\">GENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254778-genetic-technologies-to-bill-patients-directly-for-breast-cancer-test-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genetic Technologies to bill patients directly for breast cancer test; shares up 3%</a></h4><ul><li>Citing increasing difficulties getting paid for its services under a miscellaneous CPT code, Genetic Technologies (<a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='green'>+2.5%</font>) <a href=\"https://seekingalpha.com/pr/16786618-genetic-technologies-revamps-patient-pricing-billing-program-brevagenplus-r\" target=\"_blank\">announces </a>that it will change the pricing and billing structure for its BREVAGenplus breast cancer risk test from an insurance reimbursement model to directly billing patients.</li><li>The company says billing the patient directly will add certainty to the transaction and eliminate the long payment times and patient confusion related to specific insurance coverage. It adds that the new approach will also be applicable to its colorectal cancer risk assessment test which is in the latter stages of development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254778\" data-linked=\"Genetic Technologies to bill patients directly for breast cancer test; shares up 3%\" data-tweet=\"$GENE - Genetic Technologies to bill patients directly for breast cancer test; shares up 3% https://seekingalpha.com/news/3254778-genetic-technologies-to-bill-patients-directly-for-breast-cancer-test-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3254778-genetic-technologies-to-bill-patients-directly-for-breast-cancer-test-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254769\" data-ts=\"1490966660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254769-jaguar-animal-health-and-napo-pharmaceuticals-ink-formal-merger-agreement-jagx-up-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Animal Health and Napo Pharmaceuticals ink formal merger agreement; JAGX up 36% premarket</a></h4><ul><li>Jaguar Animal Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a>) is up&nbsp;<font color='green'>36%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16786897-jaguar-animal-health-napo-pharmaceuticals-enter-definitive-merger-agreement\" target=\"_blank\">announcement </a>that it has entered into a definitive merger agreement with Napo Pharmaceuticals. The deal was first announced almost two months ago.</li><li>Under the terms of the agreement, Jaguar stockholders and option and warrant holders will retain ~25% of Jaguar shares while Napo creditors, RSU, option and warrant holder will hold ~75%. Napo stockholders will receive contingent value rights (CVRs) to receive up to 21.5% of Jaguar shares upon the satisfaction of certain conditions.</li><li>Jaguar will do business as Jaguar Health after the merger, expected to close next quarter. Jaguar's current management team will lead the combined firm.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3241867-jaguar-animal-health-merge-napo-pharmaceuticals\" target=\"_blank\">Jaguar Animal Health to merge with Napo Pharmaceuticals</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254769\" data-linked=\"Jaguar Animal Health and Napo Pharmaceuticals ink formal merger agreement; JAGX up 36% premarket\" data-tweet=\"$JAGX - Jaguar Animal Health and Napo Pharmaceuticals ink formal merger agreement; JAGX up 36% premarket https://seekingalpha.com/news/3254769-jaguar-animal-health-and-napo-pharmaceuticals-ink-formal-merger-agreement-jagx-up-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3254769-jaguar-animal-health-and-napo-pharmaceuticals-ink-formal-merger-agreement-jagx-up-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254759\" data-ts=\"1490966414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254759-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-23%&nbsp;</font>on $2M private placement.</li><li><a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color='red'>-23%</font>. on equity offering.</li><li><a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='red'>-22%</font>&nbsp;on equity offering of $25M.</li><li><a href='https://seekingalpha.com/symbol/CTSO' title='Cytosorbents Corp'>CTSO</a> <font color='red'>-15%</font>&nbsp;on equity offering.</li><li><a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254759\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$AKER $DRIO $BLRX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3254759-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3254759-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254765\" data-ts=\"1490966116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254765-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TRR' title='TRC Companies, Inc.'>TRR</a> <font color='green'>+46%</font> on being acquired by P-E firm New Mountain Capital for $17.55/share.</li><li><a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+40%</font> on Q4 earnings beat.</li><li><a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+18%</font> on fast rack designation by the FDA for Coversin.</li><li><a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a> <font color='green'>+15%</font> on acquisition of crop protection business from DuPont and sale of Health and Nutrition business.</li><li><a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='green'>+13%</font> on securing two new U.S. patents covering all three of its FDA-approved products.</li><li><a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+11%</font>.</li><li>BBRY <font color='green'>+8%</font> on Q4 earnings beat.</li><li><a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='green'>+6%</font> on private placement of ~65M shares. </li><li><a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+6%</font> on upgrade to Buy with a $3.50 (77% upside) price target by H.C. Wainwright.</li><li><a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='green'>+5%</font> on chairman buying shares worth $10M.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254765\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$TRR $SORL $AKTX - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3254765-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3254765-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254756\" data-ts=\"1490965546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIU\" target=\"_blank\">ACIU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254756-ac-immune-prices-stock-offering-11-shares-down-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AC Immune prices stock offering at $11; shares down 6% premarket</a></h4><ul><li>Thinly traded AC Immune (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a>) eases&nbsp;<font color='red'>6%</font>&nbsp;premarket on light volume in response to its <a href=\"https://app.contix.com/alerts/36950226\" target=\"_blank\">public offering</a> of 1.9M shares at $11.</li><li>Yesterday's close was $11.57.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254756\" data-linked=\"AC Immune prices stock offering at $11; shares down 6% premarket\" data-tweet=\"$ACIU - AC Immune prices stock offering at $11; shares down 6% premarket https://seekingalpha.com/news/3254756-ac-immune-prices-stock-offering-11-shares-down-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254756-ac-immune-prices-stock-offering-11-shares-down-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254753\" data-ts=\"1490965099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORIG\" target=\"_blank\">ORIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254753-ocean-rig-plans-to-appeal-nasdaq-delisting-notice\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Rig plans to appeal Nasdaq delisting notice</a></h4><ul>     <li>Ocean Rig UDW (NASDAQ:<a href='https://seekingalpha.com/symbol/ORIG' title='Ocean Rig UDW Inc.'>ORIG</a>) <font color='red'>-16.9%</font> premarket after receiving a <a href=\"https://seekingalpha.com/pr/16786300-ocean-rig-announces-receipt-nasdaq-delisting-notice-application-hearing-appeal\" target=\"_blank\">Nasdaq delisting notice</a>, three days after the company <a href=\"https://seekingalpha.com/news/3253865-ocean-rig-files-chapter-15-bankruptcy-protection-shares-minus-60-percent\" target=\"_blank\">filed for Chapter 15</a> bankruptcy protection.</li>     <li>ORIG says it has requested a hearing to appeal the determination; without the appeal, trading in the stock would have been suspended at the opening on April 6.</li>     <li>Separately, the fleet value of ORIG's 14 rigs <a href=\"http://www.offshoreenergytoday.com/vesselsvalue-ocean-rigs-fleet-value-fell-40-in-one-year/\" target=\"_blank\">plunged by 40%</a> in the past year, according to VesselsValue.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254753\" data-linked=\"Ocean Rig plans to appeal Nasdaq delisting notice\" data-tweet=\"$ORIG - Ocean Rig plans to appeal Nasdaq delisting notice https://seekingalpha.com/news/3254753-ocean-rig-plans-to-appeal-nasdaq-delisting-notice?source=tweet\" data-url=\"https://seekingalpha.com/news/3254753-ocean-rig-plans-to-appeal-nasdaq-delisting-notice\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254750\" data-ts=\"1490965061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254750-sarepta-completes-sale-of-priority-review-voucher-to-gilead-for-125m-shares-ahead-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta completes sale of Priority Review Voucher to Gilead for $125M; shares ahead 1% premarket</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) <a href=\"https://seekingalpha.com/filing/3419137\" target=\"_blank\">finalizes </a>the sale of its Rare Pediatric Disease Priority Review Voucher to a subsidiary of Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) for $125M. It received the voucher, which allows for accelerated review of a future marketing application, when the FDA approved EXONDYS 51.</li><li>SRPT shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3244703-sarepta-sells-priority-review-voucher-125m-shares-ahead-2-percent-premarket\" target=\"_blank\">Sarepta sells Priority Review Voucher for $125M; shares ahead 2% premarket</a> (Feb. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254750\" data-linked=\"Sarepta completes sale of Priority Review Voucher to Gilead for $125M; shares ahead 1% premarket\" data-tweet=\"$SRPT $SRPT $GILD - Sarepta completes sale of Priority Review Voucher to Gilead for $125M; shares ahead 1% premarket https://seekingalpha.com/news/3254750-sarepta-completes-sale-of-priority-review-voucher-to-gilead-for-125m-shares-ahead-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254750-sarepta-completes-sale-of-priority-review-voucher-to-gilead-for-125m-shares-ahead-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254746\" data-ts=\"1490964279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254746-retailers-said-to-be-losing-confidence-in-monster-beverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retailers said to be losing confidence in Monster Beverage</a></h4><ul>     <li>Shares of Monster Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a>) are still on watch after Wells Fargo's Bonnie Herzog <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9241131/did-monster-beverage-overpromise-and-underdeliver-new-hy\" target=\"_blank\">warned</a>&nbsp;yesterday of a delay of the new Hydro enhanced water product. The late Hydro launch adds to a strained relationship between the company and retailers, she says.</li>     <li>\"Many retailers reported being &lsquo;let down&rsquo; with the Mutant launch (&lsquo;totally botched&rsquo;), many have &lsquo;struggled with out-of-stocks,&rsquo; and the issues with Java production have been &lsquo;going on for the whole 1st quarter,\" advises the analyst.</li>     <li>\"Given that we are approaching the key summer selling season, we have concerns about the ability for Monster&rsquo;s new innovation to have any meaningful impact on sales this year, suggesting the recent slowdown in the energy category may persist,\" she adds.</li>     <li>Monster closed at $46.26 yesterday vs. a 52-week trading range of $40.30 to $55.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254538-monsters-hydro-product-delayed-wells-fargo\" target=\"_blank\">Monster's Hydro product delayed - Wells Fargo</a> (March 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254746\" data-linked=\"Retailers said to be losing confidence in Monster Beverage\" data-tweet=\"$MNST - Retailers said to be losing confidence in Monster Beverage https://seekingalpha.com/news/3254746-retailers-said-to-be-losing-confidence-in-monster-beverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3254746-retailers-said-to-be-losing-confidence-in-monster-beverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254740\" data-ts=\"1490963397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254740-walgreens-starts-clock-on-rite-aid-merger-deadline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens starts the clock on Rite Aid merger deadline</a></h4><ul> <li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) sets a <a href=\"http://nypost.com/2017/03/30/walgreen-sets-deadline-for-9-7b-merger-with-rite-aid/\" target=\"_blank\">deadline</a> of about three months for the FTC to either block the merger with Rite Aid or let it progess, sources tell New York Post. At that time Walgreens is expected to file its certified compliance notice to the agency.</li> <li>The company appears to be betting that President Trump's pick to head the FTC will look at the deal favorably. Trump is reportedly considering Utah Attorney General Sean Reyes for the position.</li> <li>WBA <font color='green'>+0.08%</font> premarket to $83.38. Rite Aid <font color='red'>-1.58%</font> to $4.35 (52-week low).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254740\" data-linked=\"Walgreens starts the clock on Rite Aid merger deadline\" data-tweet=\"$WBA - Walgreens starts the clock on Rite Aid merger deadline https://seekingalpha.com/news/3254740-walgreens-starts-clock-on-rite-aid-merger-deadline?source=tweet\" data-url=\"https://seekingalpha.com/news/3254740-walgreens-starts-clock-on-rite-aid-merger-deadline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254738\" data-ts=\"1490962801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254738-chipotle-looks-to-extend-winning-streak\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle looks to extend winning streak</a></h4><ul> <li>Shareholders at Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) pull a proposal to split the chairman and CEO position after working out a deal with the company in which the lead director position is strengthened (<a href=\"https://seekingalpha.com/filing/3481468\" target=\"_blank\">SEC Schedule 14A</a>).</li>   <li>It's just the latest batch of favorable news that has sentiment swinging more favorable on the restaurant stock. Shares of Chipotle have recorded four straight winning sessions after positive channel checks from investment firms on Q1 comparable sales growth rolled in. A fifth day of gains could be on the way, CMG <font color='green'>+0.36%</font> premarket to $445.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254738\" data-linked=\"Chipotle looks to extend winning streak\" data-tweet=\"$CMG - Chipotle looks to extend winning streak https://seekingalpha.com/news/3254738-chipotle-looks-to-extend-winning-streak?source=tweet\" data-url=\"https://seekingalpha.com/news/3254738-chipotle-looks-to-extend-winning-streak\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254737\" data-ts=\"1490962701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRT\" target=\"_blank\">ASRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254737-depomed-ahead-9-premarket-on-starboard-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Depomed ahead 9% premarket on Starboard stake</a></h4><ul><li>Depomed (DEPO) is up&nbsp;<font color='green'>9%&nbsp;</font>premarket, albeit on only 900 shares, in apparent response to a <a href=\"https://seekingalpha.com/filing/3481208\" target=\"_blank\">13G </a>filed after the close yesterday&nbsp;that discloses an 8.8% stake (5.49M shares) by institutional investor Starboard Value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254737\" data-linked=\"Depomed ahead 9% premarket on Starboard stake\" data-tweet=\"$ASRT - Depomed ahead 9% premarket on Starboard stake https://seekingalpha.com/news/3254737-depomed-ahead-9-premarket-on-starboard-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3254737-depomed-ahead-9-premarket-on-starboard-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254727\" data-ts=\"1490961973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOFI\" target=\"_blank\">BOFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254727-nypost-feds-probe-bofi-for-money-laundering-sharesminus-7_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYPost: Feds probe BofI for money laundering; shares -7.5%</a></h4><ul><li><a href=\"http://nypost.com/2017/03/31/feds-probe-bank-of-internet-for-possible-money-laundering/\" target=\"_blank\">According to the story</a>, the DOJ has interviewed at least one former bank employee, and CEO Greg Garrabrants is also a focus of the probe.</li><li>Part of the probe is centered on regulatory filings made by <a href='https://seekingalpha.com/symbol/BOFI' title='BofI Holding, Inc.'>BOFI</a> to the OCC, according to sources.</li><li>The chief legal officer for BofI tells the <em>Post </em>the \"questions\" from federal agencies are the result of false allegations made in \"short-seller hit pieces,\" but there are no material investigations that the bank needs to make a public disclosure about.</li><li>\"I don&rsquo;t know why you&rsquo;re all of a sudden coming up with all of this silliness, and in pursuit of what,\" he asks the <em>Post</em>.</li><li>Shares&nbsp;<font color='red'>-7.5%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3254727\" data-linked=\"NYPost: Feds probe BofI for money laundering; shares -7.5%\" data-tweet=\"$BOFI - NYPost: Feds probe BofI for money laundering; shares -7.5% https://seekingalpha.com/news/3254727-nypost-feds-probe-bofi-for-money-laundering-sharesminus-7_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3254727-nypost-feds-probe-bofi-for-money-laundering-sharesminus-7_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254715\" data-ts=\"1490961272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254715-biodelivery-sciences-nabs-two-new-patents-covering-fda-approved-products-shares-ahead-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences nabs two new patents covering FDA-approved products; shares ahead 12% premarket</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) is up&nbsp;<font color='green'>12%</font>&nbsp;premarket in increased volume in response to its <a href=\"https://seekingalpha.com/pr/16786680-biodelivery-sciences-announces-granting-two-new-patents-listed-fdas-orange-book-extending\" target=\"_blank\">announcement </a>that it has secured two new U.S. patents covering all three of its FDA-approved products: BELBUCA (buprenorphine) buccal film, BUNAVAIL (buprenorphine and naloxone) buccal film and ONSOLIS (fentanyl buccal soluble film).</li><li>One patent (U.S. Patent Application 15/212912 - patent # not provided) covers the composition of the BioErodible MucoAdhesive drug delivery technology for BELBUCA and BUNAVAIL and the other ('288 patent) extends protection on ONSOLIS until July 2027.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254715\" data-linked=\"BioDelivery Sciences nabs two new patents covering FDA-approved products; shares ahead 12% premarket\" data-tweet=\"$BDSI - BioDelivery Sciences nabs two new patents covering FDA-approved products; shares ahead 12% premarket https://seekingalpha.com/news/3254715-biodelivery-sciences-nabs-two-new-patents-covering-fda-approved-products-shares-ahead-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3254715-biodelivery-sciences-nabs-two-new-patents-covering-fda-approved-products-shares-ahead-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254704\" data-ts=\"1490960031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSG\" target=\"_blank\">TSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254704-ex-amaya-ceo-sells-large-block-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ex-Amaya CEO sells large block of shares</a></h4><ul> <li>Amaya (AYA) discloses that David Baazov sold 12M shares on March 29 and March 30 at an average price of C$22.31.</li> <li>Baazov, who resigned as Amaya CEO last August, still holds a 3.8% stake in the company through his 5.605M shares.</li> <li><a href=\"https://www.sec.gov/Archives/edgar/data/1635327/000095015717000433/sc13da.htm\" target=\"_blank\">SEC Form 13D/A</a></li> <li>AYA <font color='green'>+1.43%</font> premarket to $17.40. The Toronto-traded shares closed at $22.89 yesterday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254704\" data-linked=\"Ex-Amaya CEO sells large block of shares\" data-tweet=\"$TSG - Ex-Amaya CEO sells large block of shares https://seekingalpha.com/news/3254704-ex-amaya-ceo-sells-large-block-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3254704-ex-amaya-ceo-sells-large-block-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254698\" data-ts=\"1490959157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254698-blackberry-up-4_3-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry up 4.3% after earnings beat</a></h4><ul><li>Non-GAAP operating income of $13M or $0.04 per share in FQ4. GAAP operating loss of $57M.</li><li>Total and equivalents up $89M to $1.7B as of Fed. 28. Net cash balance post-debt of $1.1B.</li><li>Company expects to be profitable on a non-GAAP basis in fiscal 2018, and generate positive free cash flow.</li><li><a href=\"http://ca.blackberry.com/company/investors/events.html\" target=\"_blank\">Conference call</a> at 8 ET</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254683-blackberry-beats-0_08-beats-revenue\" target=\"_blank\">BlackBerry beats by $0.08, beats on revenue</a> (March 31)</li><li>BBRY&nbsp;<font color='green'>+4.3%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3254698\" data-linked=\"BlackBerry up 4.3% after earnings beat\" data-tweet=\"$BB - BlackBerry up 4.3% after earnings beat https://seekingalpha.com/news/3254698-blackberry-up-4_3-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3254698-blackberry-up-4_3-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254695\" data-ts=\"1490958959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWDP\" target=\"_blank\">DWDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254695-dupont-sells-part-of-crop-protection-business-to-fmc-for-1_2b-and-health-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DuPont sells part of crop protection business to FMC for $1.2B and health unit</a></h4><ul>     <li>DuPont (DD) <a href=\"https://seekingalpha.com/pr/16786644-dupont-announces-agreement-fmc\" target=\"_blank\">agrees to sell</a> part of its crop protection business to FMC Corp. (NYSE:<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a>) for $1.2B in cash and the acquisition of FMC Health and Nutrition.</li>     <li>DuPont says the sale will satisfy its commitments to the European Commission for regulatory clearance of its merger with Dow Chemical (DOW), which is now expected to close between Aug. 1 and Sept. 1, later than previously planned.</li><li>DuPont says FMC's Health &amp; Nutrition business  generated more than $700M in revenues in 2016, and is highly complementary to its existing Nutrition  &amp; Health business.</li>     <li>FMC says the acquisition will make it the <a href=\"https://seekingalpha.com/pr/16786645-fmc-corporation-announces-acquisition-significant-portion-duponts-crop-protection-business\" target=\"_blank\">world's fifth largest</a> crop protection chemical company, and will generate ~$1.5B in revenue and $475M of EBITDA this year.</li><li>FMC&nbsp;<font color='green'>+5.7%</font> premarket, DD&nbsp;<font color='green'>+0.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254695\" data-linked=\"DuPont sells part of crop protection business to FMC for $1.2B and health unit\" data-tweet=\"$DWDP $DD $FMC - DuPont sells part of crop protection business to FMC for $1.2B and health unit https://seekingalpha.com/news/3254695-dupont-sells-part-of-crop-protection-business-to-fmc-for-1_2b-and-health-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3254695-dupont-sells-part-of-crop-protection-business-to-fmc-for-1_2b-and-health-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254691\" data-ts=\"1490958643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SORL\" target=\"_blank\">SORL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254691-sorl-auto-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SORL Auto higher on earnings beat</a></h4><ul>     <li>SORL Auto (NASDAQ:<a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a>) reports Domestic&nbsp;aftermarket sales expanded 93.8% to $31M in <a href=\"https://seekingalpha.com/pr/16786633-sorl-auto-parts-reports-approximately-40-percent-rise-net-income-fourth-quarter-2016\" target=\"_blank\">Q4</a>.</li>     <li>Domestic OEM customers sales grew 53.7% to $39.2M due to growing total truck sales.</li>     <li>International sales fell 17.6% to $12.6M&nbsp;due to lower demand in several overseas markets.</li>     <li>Total truck sales increased 21.4%, led by 69.5% growth in the heavy-duty segment.</li>     <li>Gross margin rate down 420 bps to 20.7%.</li>     <li>Operating margin rate increased 210 bps 12.9%.</li>     <li><b>FY2017 Guidance</b>: Net sales: ~$300M; Net income: ~$21M.</li><li>SORL&nbsp;<font color='green'>+28.84%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254691\" data-linked=\"SORL Auto higher on earnings beat\" data-tweet=\"$SORL - SORL Auto higher on earnings beat https://seekingalpha.com/news/3254691-sorl-auto-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3254691-sorl-auto-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254683\" data-ts=\"1490958194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254683-blackberry-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry beats by $0.08, beats on revenue</a></h4><ul><li>BlackBerry (BBRY): Q4 EPS of $0.04 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $297M (-36.0% Y/Y) <font color='green'>beats by $3M</font>.</li><li>Shares <font color='green'>+3.3%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16786703-blackberry-reports-q4-fiscal-2017-results-analyst-consensus-revenue-eps-estimates'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254683\" data-linked=\"BlackBerry beats by $0.08, beats on revenue\" data-tweet=\"$BB - BlackBerry beats by $0.08, beats on revenue https://seekingalpha.com/news/3254683-blackberry-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3254683-blackberry-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254681\" data-ts=\"1490958125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSO\" target=\"_blank\">CTSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254681-cytosorbents-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytoSorbents readies equity offering</a></h4><ul><li>Thinly traded micro cap CytoSorbents (NASDAQ:<a href='https://seekingalpha.com/symbol/CTSO' title='Cytosorbents Corp'>CTSO</a>) eases&nbsp;<font color='red'>7%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16786279-cytosorbents-announces-proposed-offering-common-stock\" target=\"_blank\">announcement </a>of a public offering of common stock. Price, volume and terms have yet to be released. Net proceeds will fund working capital and general corporate purposes.</li><li>Yesterday's close was $5.45.</li><li><strong>Update</strong>: The <a href=\"https://seekingalpha.com/pr/16786752-cytosorbents-announces-pricing-follow-offering\" target=\"_blank\">offering </a>is 2,222,222 shares of common stock at $4.50. Underwriters over-allotment is an additional 333,333 shares. Closing date is April 5. Shares are down&nbsp;<font color='red'>14%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254681\" data-linked=\"CytoSorbents readies equity offering\" data-tweet=\"$CTSO - CytoSorbents readies equity offering https://seekingalpha.com/news/3254681-cytosorbents-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3254681-cytosorbents-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254677\" data-ts=\"1490957870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254677-biolinerx-launches-equity-offering-shares-off-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx launches equity offering; shares off 17% premarket</a></h4><ul><li>BioLineRx (NASDAQ:<a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a>) slumps&nbsp;<font color='red'>17%&nbsp;</font>premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16786281-biolinerx-announces-underwritten-public-offering-american-depositary-shares\" target=\"_blank\">announcement </a>of a public offering of American Depositary Shares (ADSs), each representing one ordinary share. Price, volume and terms have yet to be released.</li><li>Yesterday's close was $1.15.</li><li><strong>Update</strong>: The <a href=\"https://seekingalpha.com/pr/16786796-biolinerx-prices-25-million-underwritten-public-offering\" target=\"_blank\">offering </a>is 29.4M ADSs at $0.85 per ADS for gross proceeds of $25M. Underwriters over-allotment is an additional 4.4M ADSs. Net proceeds will fund clinical trials, working capital and general corporate purposes. Shares are down&nbsp;<font color='red'>22%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254677\" data-linked=\"BioLineRx launches equity offering; shares off 17% premarket\" data-tweet=\"$BLRX - BioLineRx launches equity offering; shares off 17% premarket https://seekingalpha.com/news/3254677-biolinerx-launches-equity-offering-shares-off-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254677-biolinerx-launches-equity-offering-shares-off-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254675\" data-ts=\"1490957675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRIO\" target=\"_blank\">DRIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254675-dariohealth-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarioHealth readies equity offering</a></h4><ul><li>Thinly traded nano cap DarioHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a>) slumps&nbsp;<font color='red'>17%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16786355-dariohealth-corp-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcement </a>of a planned equity offering. Price, volume and terms have yet to be announced. Net proceeds will fund product commercialization activities and working capital.</li><li>Yesterday's close was $3.90.</li><li><strong>Update</strong>: The <a href=\"https://seekingalpha.com/pr/16786763-dariohealth-corp-prices-offering-1450-000-shares-common-stock\" target=\"_blank\">offering </a>is 1.45M shares of common stock at $3.10. Underwriters over-allotment is an additional 217.5K shares. Closing date is April 5. Shares are down 23% premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254675\" data-linked=\"DarioHealth readies equity offering\" data-tweet=\"$DRIO - DarioHealth readies equity offering https://seekingalpha.com/news/3254675-dariohealth-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3254675-dariohealth-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254670\" data-ts=\"1490957158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARA\" target=\"_blank\">CARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254670-cara-therapeutics-prices-stock-offering-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cara Therapeutics prices stock offering at $18</a></h4><ul><li>Cara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a>) <a href=\"https://seekingalpha.com/pr/16786557-cara-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 4.45M shares of common stock at $18 per share. Underwriters over-allotment is an additional 667.5K shares. Closing date is April 5.</li><li>Net proceeds will fund clinical and research activities, working capital and general corporate purposes.</li><li>Yesterday's close was $18.76. Shares are up a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254670\" data-linked=\"Cara Therapeutics prices stock offering at $18\" data-tweet=\"$CARA - Cara Therapeutics prices stock offering at $18 https://seekingalpha.com/news/3254670-cara-therapeutics-prices-stock-offering-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3254670-cara-therapeutics-prices-stock-offering-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":47,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}